Abstract |
NO. Insulin glargine may lead to less patient-reported, symptomatic, and nocturnal hypoglycemia, although overall, there may not be a difference in the risk for severe hypoglycemia orhypoglycemiarelated emergency department (ED) visits and hospitalizations (strength of recommendation [SOR]: B, systematic review of randomized controlled trials [RCTs], individual RCTs, and observational study).
|
Authors | Corey Lyon, Swetha Iruku, Molly Hoss, Kristen DeSanto, Richard Guthmann |
Journal | The Journal of family practice
(J Fam Pract)
Vol. 70
Issue 4
Pg. E5-E6
(05 2021)
ISSN: 1533-7294 [Electronic] United States |
PMID | 34339367
(Publication Type: Comparative Study, Journal Article, Meta-Analysis, Systematic Review)
|
Chemical References |
- Insulin Glargine
- Insulin, Isophane
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Diabetes Mellitus, Type 2
(drug therapy)
- Female
- Humans
- Hypoglycemia
(chemically induced)
- Insulin Glargine
(adverse effects, therapeutic use)
- Insulin, Isophane
(adverse effects, therapeutic use)
- Male
- Middle Aged
- Treatment Outcome
|